From the Guidelines

Corticosteroids are not recommended for the treatment of hip pointer.

The provided evidence does not support the use of corticosteroids for hip pointer treatment, as it focuses on osteoarthritis (OA) management 1.
Intra-articular corticosteroid injections (CSIs) are beneficial for patients with persistent OA-related hip pain, but this is a different condition from hip pointer 1.
Methylprednisolone and triamcinolone are examples of corticosteroids used for OA-related knee pain, but their use for hip pointer is not mentioned in the evidence 1.
Hip injections require image guidance to ensure safety due to joint depth and proximity to vascular and neural structures 1.
The evidence highlights the potential long-term negative effects on bone health, joint structure, and meniscal thickness associated with repeat intra-articular corticosteroid administration 1.

From the Research

The use of corticosteroids for the treatment of hip pointer is not directly addressed in the provided studies, as they focus on osteoarthritis, greater trochanteric pain syndrome, and rapidly destructive hip disease.
However, the studies provide information on the use of corticosteroids in the treatment of hip-related conditions, which may be relevant to hip pointer treatment.
A study published in 2016 2 found that corticosteroids are effective in alleviating pain from hip osteoarthritis, and that a higher dose of corticosteroids produces a longer benefit.
Another study published in 2004 3 found that intraarticular corticosteroid injections can provide quick pain relief and improve functional ability in patients with hip osteoarthritis.
A study published in 2017 4 compared the effectiveness of dry needling and cortisone injection in the treatment of greater trochanteric pain syndrome, and found that dry needling is noninferior to cortisone injection in reducing lateral hip pain and improving function.
A study published in 2021 5 found an association between hip corticosteroid injection and rapidly destructive hip disease, and suggested that caution should be taken with intra-articular hip injections utilizing high-dose corticosteroids and multiple injections.

The use of corticosteroids for hip pointer treatment may be associated with potential risks, such as rapidly destructive hip disease, as reported in the 2021 study 5.
However, corticosteroids may also provide benefits, such as pain relief and improved functional ability, as reported in the 2004 study 3 and the 2016 study 2.
The decision to use corticosteroids for hip pointer treatment should be made on a case-by-case basis, taking into account the individual patient's condition and medical history, as well as the potential risks and benefits of the treatment.

Intra-articular corticosteroid injections may be used to treat hip-related conditions, including osteoarthritis and greater trochanteric pain syndrome.
The injections can be administered using various techniques, including fluoroscopy and ultrasound guidance, as reported in the 2016 study 2.
The effectiveness of intra-articular corticosteroid injections may depend on various factors, including the dose and type of corticosteroid used, as well as the individual patient's condition and medical history.